
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $22.3M | $15.2M | $14M | $10.7M | $4.7M | |
Selling, General & Admin | $9.4M | $9.3M | $10.9M | $10.7M | $7M | |
Other Inc / (Exp) | -- | -- | -- | $4.7M | $147K | |
Operating Expenses | $31.7M | $24.5M | $24.8M | $21.4M | $11.7M | |
Operating Income | -$31.7M | -$24.5M | -$24.8M | -$21.4M | -$11.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$31.8M | -$24.5M | -$24.3M | -$17.2M | -$11.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$31.8M | -$24.5M | -$24.3M | -$17.2M | -$11.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$31.8M | -$24.5M | -$24.3M | -$17.2M | -$11.6M | |
Basic EPS (Cont. Ops) | -$16.05 | -$10.20 | -$9.90 | -$6.00 | -$2.31 | |
Diluted EPS (Cont. Ops) | -$16.05 | -$10.20 | -$9.90 | -$6.00 | -$2.31 | |
Weighted Average Basic Share | $2M | $2.4M | $2.4M | $2.9M | $5M | |
Weighted Average Diluted Share | $2M | $2.4M | $2.4M | $2.9M | $5M | |
EBITDA | -$31.5M | -$24.3M | -$24.5M | -$21.2M | -$11.5M | |
EBIT | -$31.7M | -$24.5M | -$24.8M | -$21.4M | -$11.7M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$31.7M | -$24.5M | -$24.8M | -$21.4M | -$11.7M | |
Operating Income (Adjusted) | -$31.7M | -$24.5M | -$24.8M | -$21.4M | -$11.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $4.3M | $2.6M | $2.9M | $961K | $1.3M | |
Selling, General & Admin | $2.6M | $2.9M | $2.2M | $1.5M | $1.8M | |
Other Inc / (Exp) | -- | -- | -- | -$940K | $179K | |
Operating Expenses | $6.9M | $5.5M | $5.2M | $2.5M | $3.1M | |
Operating Income | -$6.9M | -$5.5M | -$5.2M | -$2.5M | -$3.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$6.7M | -$5.4M | -$5.1M | -$3.4M | -$2.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$6.7M | -$5.4M | -$5.1M | -$3.4M | -$2.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$6.7M | -$5.4M | -$5.1M | -$3.4M | -$2.9M | |
Basic EPS (Cont. Ops) | -$2.85 | -$2.25 | -$2.10 | -$0.75 | -$0.45 | |
Diluted EPS (Cont. Ops) | -$2.85 | -$2.25 | -$2.10 | -$0.75 | -$0.45 | |
Weighted Average Basic Share | $2.4M | $2.4M | $2.4M | $4.3M | $6.3M | |
Weighted Average Diluted Share | $2.4M | $2.4M | $2.4M | $4.3M | $6.3M | |
EBITDA | -$6.9M | -$5.4M | -$5.1M | -$2.4M | -$3M | |
EBIT | -$6.9M | -$5.5M | -$5.2M | -$2.5M | -$3.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$6.9M | -$5.5M | -$5.2M | -$2.5M | -$3.1M | |
Operating Income (Adjusted) | -$6.9M | -$5.5M | -$5.2M | -$2.5M | -$3.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $20.7M | $13.5M | $14.3M | $8.8M | $5M | |
Selling, General & Admin | $9.6M | $9.6M | $10.2M | $10M | $7.3M | |
Other Inc / (Exp) | -- | -- | -- | $3.8M | $1.3M | |
Operating Expenses | $30.3M | $23.1M | $24.5M | $18.8M | $12.3M | |
Operating Income | -$30.3M | -$23.1M | -$24.5M | -$18.8M | -$12.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$30.4M | -$23.2M | -$24M | -$15.5M | -$11.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$30.3M | -$23.2M | -$24M | -$15.5M | -$11.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$30.4M | -$23.2M | -$24M | -$15.5M | -$11.1M | |
Basic EPS (Cont. Ops) | -$14.25 | -$9.60 | -$9.75 | -$4.80 | -$2.07 | |
Diluted EPS (Cont. Ops) | -$14.25 | -$9.60 | -$9.75 | -$4.80 | -$2.07 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$30.1M | -$22.8M | -$24.2M | -$18.5M | -$12.1M | |
EBIT | -$30.3M | -$23.1M | -$24.5M | -$18.8M | -$12.3M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$30.3M | -$23.1M | -$24.5M | -$18.8M | -$12.3M | |
Operating Income (Adjusted) | -$30.3M | -$23.1M | -$24.5M | -$18.8M | -$12.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $4.3M | $2.6M | $2.9M | $961K | $1.3M | |
Selling, General & Admin | $2.6M | $2.9M | $2.2M | $1.5M | $1.8M | |
Other Inc / (Exp) | -- | -- | -- | -$940K | $179K | |
Operating Expenses | $6.9M | $5.5M | $5.2M | $2.5M | $3.1M | |
Operating Income | -$6.9M | -$5.5M | -$5.2M | -$2.5M | -$3.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$6.7M | -$5.4M | -$5.1M | -$3.4M | -$2.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$6.7M | -$5.4M | -$5.1M | -$3.4M | -$2.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$6.7M | -$5.4M | -$5.1M | -$3.4M | -$2.9M | |
Basic EPS (Cont. Ops) | -$2.85 | -$2.25 | -$2.10 | -$0.75 | -$0.45 | |
Diluted EPS (Cont. Ops) | -$2.85 | -$2.25 | -$2.10 | -$0.75 | -$0.45 | |
Weighted Average Basic Share | $2.4M | $2.4M | $2.4M | $4.3M | $6.3M | |
Weighted Average Diluted Share | $2.4M | $2.4M | $2.4M | $4.3M | $6.3M | |
EBITDA | -$6.9M | -$5.4M | -$5.1M | -$2.4M | -$3M | |
EBIT | -$6.9M | -$5.5M | -$5.2M | -$2.5M | -$3.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$6.9M | -$5.5M | -$5.2M | -$2.5M | -$3.1M | |
Operating Income (Adjusted) | -$6.9M | -$5.5M | -$5.2M | -$2.5M | -$3.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $37.8M | $18.9M | $772K | $1.3M | $187K | |
Short Term Investments | $4.1M | $3.2M | $2.2M | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1M | $1.1M | $32K | $548K | $135K | |
Total Current Assets | $43.2M | $23.3M | $3.1M | $1.9M | $385K | |
Property Plant And Equipment | $8M | $6M | $5.3M | $2.1M | $1.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $27K | -- | $207K | $206K | |
Total Assets | $51.3M | $29.3M | $8.5M | $4.2M | $1.8M | |
Accounts Payable | $7.3M | $4.8M | $6.2M | $5M | $6.1M | |
Accrued Expenses | $1.3M | $83K | $84K | $1.2M | $619K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $2.7M | $1.5M | $1.4M | $603K | $549K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $11.2M | $6.3M | $8.8M | $7.8M | $9M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $15.8M | $9.9M | $11.5M | $9.1M | $9.6M | |
Common Stock | $12K | $12K | $12K | $13K | $14K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $35.5M | $19.3M | -$3M | -$4.9M | -$7.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $35.5M | $19.3M | -$3M | -$4.9M | -$7.8M | |
Total Liabilities and Equity | $51.3M | $29.3M | $8.5M | $4.2M | $1.8M | |
Cash and Short Terms | $41.9M | $22.1M | $3M | $1.3M | $187K | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $35.9M | $15.2M | $2M | $779K | $1.6M | |
Short Term Investments | $4.1M | $3.2M | $206K | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | $285K | -- | |
Other Current Assets | $728K | $802K | $658K | $169K | $621K | |
Total Current Assets | $41M | $19.3M | $2.9M | $1.3M | $2.3M | |
Property Plant And Equipment | $7.5M | $6.5M | $4.9M | $1.9M | $1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | $23K | $202K | $204K | |
Total Assets | $48.6M | $25.8M | $7.9M | $3.3M | $3.6M | |
Accounts Payable | $4.1M | $5.7M | $8.9M | $4.7M | $6.8M | |
Accrued Expenses | $1.7M | $71K | $171K | $636K | $538K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $1.2M | |
Current Portion Of Capital Lease Obligations | $2.3M | $1.6M | $1.4M | $588K | $443K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $8.2M | $7.4M | $10.4M | $6.8M | $10.9M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $12.4M | $11.3M | $12.7M | $8.9M | $11M | |
Common Stock | $12K | $12K | $12K | $13K | $15K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $36.2M | $14.5M | -$4.8M | -$5.6M | -$7.5M | |
Total Liabilities and Equity | $48.6M | $25.8M | $7.9M | $3.3M | $3.6M | |
Cash and Short Terms | $40M | $18.4M | $2.2M | $779K | $1.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$31.8M | -$24.5M | -$24.3M | -$17.2M | -$11.6M | |
Depreciation & Amoritzation | $219K | $260K | $285K | $265K | $240K | |
Stock-Based Compensation | $2.6M | $1.4M | $1.7M | $1.5M | $750K | |
Change in Accounts Receivable | $1.5M | $335K | $1.1M | -$475K | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$35.2M | -$26.3M | -$19.3M | -$20.5M | -$9.1M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$4.5M | $323K | $998K | $2.2M | $12K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$116K | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $76.9M | $7M | $238K | $19M | $8M | |
Beginning Cash (CF) | $536K | $37.8M | $18.9M | $772K | $1.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $37.3M | -$19M | -$18.1M | $713K | -$1.1M | |
Ending Cash (CF) | $37.8M | $18.9M | $772K | $1.5M | $371K | |
Levered Free Cash Flow | -$35.6M | -$26.6M | -$19.3M | -$20.5M | -$9.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$6.7M | -$5.4M | -$5.1M | -$3.4M | -$2.9M | |
Depreciation & Amoritzation | $61K | $74K | $67K | $64K | $52K | |
Stock-Based Compensation | $290K | $505K | $4K | $170K | $717K | |
Change in Accounts Receivable | $322K | $323K | -$579K | $121K | -$490K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$9M | -$3.7M | -$4M | -$3.1M | -$1.6M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$37K | -$17K | $2M | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $900K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $7.1M | -- | $3.2M | $2.5M | $3.1M | |
Beginning Cash (CF) | $37.8M | $18.9M | $772K | $1.5M | $371K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.9M | -$3.7M | $1.2M | -$524K | $1.5M | |
Ending Cash (CF) | $35.9M | $15.2M | $2M | $961K | $1.8M | |
Levered Free Cash Flow | -$9M | -$3.7M | -$4M | -$3.1M | -$1.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$30.3M | -$23.2M | -$24M | -$15.5M | -$11.1M | |
Depreciation & Amoritzation | $231K | $273K | $278K | $262K | $228K | |
Stock-Based Compensation | $2.5M | $1.6M | $1.2M | $1.7M | $1.3M | |
Change in Accounts Receivable | -$265K | $336K | $165K | $700K | -$611K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$29.1M | -$21M | -$19.6M | -$19.5M | -$7.7M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.5M | $343K | $3M | $188K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $55.1M | -$140K | $3.5M | $18.3M | $8.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $23.5M | -$20.8M | -$13.1M | -$1.1M | $865K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$29.5M | -$21.3M | -$19.6M | -$19.5M | -$7.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$6.7M | -$5.4M | -$5.1M | -$3.4M | -$2.9M | |
Depreciation & Amoritzation | $61K | $74K | $67K | $64K | $52K | |
Stock-Based Compensation | $290K | $505K | $4K | $170K | $717K | |
Change in Accounts Receivable | $322K | $323K | -$579K | $121K | -$490K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$9M | -$3.7M | -$4M | -$3.1M | -$1.6M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$37K | -$17K | $2M | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $900K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $7.1M | -- | $3.2M | $2.5M | $3.1M | |
Beginning Cash (CF) | $37.8M | $18.9M | $772K | $1.5M | $371K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.9M | -$3.7M | $1.2M | -$524K | $1.5M | |
Ending Cash (CF) | $35.9M | $15.2M | $2M | $961K | $1.8M | |
Levered Free Cash Flow | -$9M | -$3.7M | -$4M | -$3.1M | -$1.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.